Convalescent plasma (CP) therapy to treat hospitalised COVID-19 patients has received emergency use authorisation (EUA) from the FDA in the United States. This kind of therapy is a classic prevention and treatment strategy against infectious diseases that has been in use for many decades.

Continue reading

Try our 7-day free trial and access the full article with citations and resources.

Try For Free Already have an account? Sign in